←Back to Expert Scholars
Translational Medicine / 转化医学Breast Cancer Translational Research
Peter Fasching
MD
🏢University Hospital Erlangen🌐Germany
Professor of Translational Medicine
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Peter Fasching leads translational breast cancer research in Germany and has contributed to studies of endocrine therapy and CDK4/6 inhibitors in both ductal and lobular disease. His work integrates germline genetics with treatment response. He leads multiple national and international trials.
Share:
🧪Research Fields 研究领域
breast cancer
germline genetics
lobular carcinoma
clinical trials
CDK4/6 inhibitors
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Peter Fasching 的研究动态
Follow Peter Fasching's research updates
留下邮箱，当我们发布与 Peter Fasching（University Hospital Erlangen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment